VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results.
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results. Leukemia. 2020 11; 34(11):2903-2913.
View in:
PubMed
subject areas
Adult
Aged
Aniline Compounds
Antineoplastic Agents
Benzimidazoles
Bone Marrow
DNA Mutational Analysis
Enzyme Inhibitors
Female
Humans
Isocitrate Dehydrogenase
Leukemia, Myeloid, Acute
Male
Middle Aged
Molecular Targeted Therapy
Mutation
Prognosis
Survival Analysis
Treatment Outcome
authors with profiles
COURTNEY DINARDO